Jason Scott Slakter, Chief Executive Officer at Ohr Pharmaceutical Inc (OHRP), bought 285,716 shares at $0.70 ($200K) on 2017-04-10, disclosed to the SEC on 2017-04-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.70 | 142,858 | $100K | 50.0% |
| 2 | $0.70 | 142,858 | $100K | 50.0% |
| Total | $0.70 avg | 285,716 | $200K | 100% |
| Filing → |
| OHRP | BUY | 2016-05-25 | $89K | — | Filing → |
| OHRP | BUY | 2016-04-12 | $21K | — | Filing → |
| OHRP | BUY | 2016-03-09 | $23K | — | Filing → |